Elektron Technology plc (LON:EKT) said it has completed the sale of subsidiary Queensgate Nano to Prior Scientific Instruments Ltd in a deal worth up to ?1.6mln, sending its shares higher.
The speciality device maker will receive an initial cash consideration of ?800,000 and will be entitled to 50% of product sales revenue above ?900,000 in the 12 months after completion of the deal. The additional consideration has a cap of ?800,000.
"The disposal of Queensgate represents the final step in our strategy of simplifying our operations and will enable management to focus solely on those businesses which the board believes offer potential for sales and margin growth, namely Bulgin, Checkit and Elektron Eye Technology", Elektron chief executive John Wilson said.
Shares rose 5.4% to 23.40p.
Shares in fishing tackle retailer Angling Direct plc (LON:ANG) rose 4.6% to 101.5p after reporting a 44% rise in full year revenue.
Revenue grew to ?30.2mln in the year to January 31 from ?21mln last year, boosted by growth across its retail and e-commerce divisions.
The retailer said it has a "very positive outlook" despite higher labour costs, increased margin pressure and growing uncertainty across the wider economic and consumer environment.
It said investment in its e-commerce platform has bared fruit as more consumers shop online and new store openings should also support growth. "The board remains confident of continued strong growth this year and beyond."
Advanced Oncotherapy PLC (LON:AVO) said Chinese authorities have approved the transfer of the ?13.5mln owed by Yantai Cipu Medical Technology Co Ltd for the subscription of 45 million shares.
In reaction, shares edged up 6.6% to 56.50p.
The company, which develops next-generation proton therapy systems for cancer treatment, said it has now completed its placing of more than 10.8 million shares and the conversion of the loan made by Swedish investors into 13.6m million shares following the subscription by Yantai.
Advanced Oncotherapy signed a distribution agreement with Yantai CIPU in December. Under the deal, Yantai will market and sell Advanced Oncotherapy's LIGHT proton therapy system.
Yantai is in advanced talks with a major medical equipment and pharmaceutical distribution company in China for a collaboration to strengthen market access in China, Macau, Hong Kong, Taiwan and South Korea.
"The company and Yantai Cipu have agreed that it is in the best interest of the company and its shareholders to extend the long stop date for the distribution agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant," Advanced Oncotherapy said.
Beowulf Mining plc (LON:BEM) shares edged higher as it said drilling at its Aitolampi graphite project is underway.
Aitolampi is part of the company's wholly-owned exploration Permit Pitk??j??rvi 1 in Finland.
The company plans to drill about 2,000 metres, up to 15 drill holes, split into two phases.
The drilling contract has been awarded to a local Finnish contractor, Oy Northdrill.
Shares rose 7.8% to 8.5p.
Sunrise Resources Plc (LON:SRES) also gained after unveiling positive results from the phase 2 of drilling at the CS pozzolan-perlite project in Nevada.
The company completed 25 reverse circulation percussion drill holes at 838m to better define the zones of commercial interest and assist in the preparation of mine plans for permitting.
Thick zones of Tuff pozzolan were intersected from bedrock surface in all but one of eight holes drilled in the Tuff Zone while thick perlite intersections of up to 26m were encountered in the Main Zone.
Shares increased 7.14% to 0.15p.
Plant Impact PLC (LON: PIM) shares jumped 65% to 9.75p after the Europe subsidiary of Croda International PLC (LON:CRDA) agreed to buy the crop enhancement technology firm for ?10mln.
Shareholders in Plant Impact will receive 10.57p in cash for each ordinary share, representing a 79.9% premium to the closing price on Thursday.
Plant Impact said it considers the terms of the offer to be fair and reasonable and will recommend shareholders vote in favour of the deal.
The company started a formal sales process in December for some or all of its assets after lowering its full year revenue guidance and saying it needs funding following a reduction in cash flows.
Chinese speciality chemicals company HaiKe Chemical Group Ltd (LON:HAIK) said it intends to seek shareholder approval to cancel its admission to trading on AIM.
Shares shot up 48% to 27.5p.
The company said a highly competitive market means it may require a "significant" injection of capital to upgrade its production facilities and plant.
"It is the directors' view that the continued admission to AIM is unlikely to provide the company with access to such capital, if required, and that funding could be secured more easily if it is no longer admitted to AIM," it explained.#
On the downside, CVS Group PLC (LON:CVSG) shares fell 11% to 1,083p after the veterinary services company said it plans raise more than ?67mln in a share placement.
The group will place up to 6.3 million new ordinary shares at a price expected to be no less than 1,050p, representing a 13.9% discount to the closing price on Thursday.
Proceeds will be used to pay down debt and to fund acquisitions, including ?40mln of deals in the UK and Netherlands that are expected to be completed in the next six months.
Zenith Energy PLC (LON:ZEN) was on the back foot as it said third quarter production from its wells in Azerbaijan were suspended in the third quarter due to field rehabilitation operations.
Daily production from the field was also affected as a result of receiving faulty chemical to treat its oil production from an international chemical supplier.
Shares fell 3% to 7,75p.
Zenith said it was now seeking to have the faulty chemical replaced and has ordered new chemical supplies to avoid similar problems being incurred in future.
W Resources PLC (LON:WRES) told investors it has secured a US$35mln loan and in doing so it ensures that the La Parrilla mine development is fully funded. BlackRock Financial Management is providing the loan, which will have a five-year schedule term (with the option for early repayment) and it has an average interest rate of 12.6%.
Sunrise Resources Plc (LON:SRES) has announced positive results from the phase 2 of drilling at the CS pozzolan-perlite project in Nevada. The company completed 25 reverse circulation percussion drill holes at 838m to better define the zones of commercial interest and assist in the preparation of mine plans for permitting.
Learning Technologies Group PLC (LON:LTG), the leading integrated e-learning services and technologies provider, announced that it has appointed Goldman Sachs International as joint corporate broker alongside Numis Securities.
Hummingbird Resources PLC (LON:HUM) said on Friday its Yanfolila gold mine in Mali has steadily been ramping up towards full production since first gold was poured in December. The plant has achieved around 96% gold recoveries consistently since the start of operations, which is higher than design specification.
Victoria Oil & Gas plc (LON:VOG) told investors that fourth quarter gas sales were up 18.56% from the preceding three months. Gross sales amounted to 726mln cubic feet in the fourth quarter, which also represents an 11% increase in the year-on-year comparative. Daily gas production averaged 7.94mln cubic feet per day, up from 6.96mln cubic feet in the third quarter and 7.64mln in the fourth quarter of 2016.
Galantas Gold Corp (LON:GAL) said the Court of Appeal at the Royal Courts of Justice in Belfast, Northern Ireland has completed its hearing on an appeal by a third party regarding the granting of planning permission to the firm's gold mine in Omagh.
Scotgold Resources Limited (LON:SGZ) has received a boost to its plans to open an underground gold mine at Cononish. The Director of Rural Planning and Development at the Loch Lomond and the Trossachs National Park Authority has issued a report recommending approval of the company's application, subject to an S75 planning agreement.
Accesso Technology Group PLC (LON:ACSO) has appointed Royce Paul Noland Jr. as the ticket and queue management company's new chief executive officer and said he will join the board on 9 April 2018. The AIM-listed firm noted that Noland was president and CEO of the International Association of Amusement Parks and Attractions and has acted in a number of senior executive roles with Walt Disney Parks and Resorts and Marriot International.
Faron Pharmaceuticals Oy (LON:FARN) has topped up its balance sheet with a ?15mln funding to accelerate the development of its two lead products. A placing and subscription at 805p, the closing price yesterday, will bring in a net ?14.1mln to add to an existing cash balance of ?,?9.3mln.
Advanced Oncotherapy PLC (LON:AVO), the developer of next-generation proton therapy systems for cancer treatment said it has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer of the ?13.5mln payable under the subscription for 45mln new ordinary shares to be issued by the company to Yantai Cipu at a price of 30p per share. The firm added that Yantai Cipu has also informed the company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea.
Concepta PLC (LON:CPT) the UK healthcare company and developer of a proprietary product targeted at the mobile health market with a primary focus on women's fertility, announced the appointment of David Darrock, its chief operating officer, as a director of Concepta Diagnostics Ltd. Alongside Darrock's appointment, and to strengthen the China team, the group added, Michelle Yao has been appointed as Concepta's China General Manager, and will be reporting to Zhang Zi Gang, the UK-based Head of China.
Goldplat plc (LON:GDP), the AIM listed gold producer with international recovery operations located in South Africa and Ghana and a mine in Kenya, announced the appointment of WH Ireland as it sole broker with immediate effect.
Scancell Holdings Plc (LON:SCLP), the developer of novel immunotherapies for the treatment of cancer, announced that its chief executive officer, Cliff Holloway, and Lindy Durrant, chief scientific officer, have been invited to present an overview of the company alongside recognised experts in the fields of melanoma, lung cancer and the development of innovative immunotherapies, at the Calculus Investor Forum in London on Friday 16 February 2018 at 12.15pm GMT.